Related Experiment Video
Updated: Dec 7, 2025

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
Adenosine Signaling in Autoimmune Disorders
Giulia Magni1, Stefania Ceruti1
1Laboratory of Cellular and Molecular Pharmacology of Purinergic Transmission, Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20133 Milan, Italy.
Adenosine, a key molecule in the purinergic system, modulates immune responses. Targeting adenosine receptors offers a novel anti-inflammatory strategy for autoimmune disorders, with promising clinical trial data.
Area of Science:
- Immunology
- Pharmacology
- Molecular Biology
Background:
- The purinergic system, including adenosine, is integral to immune cell function.
- Adenosine is generated during cellular stress and acts as an anti-inflammatory mediator.
- Dysregulated adenosine signaling may contribute to autoimmune diseases.
Purpose of the Study:
- To review the role of adenosine in immune cells.
- To explore adenosine-based therapies for autoimmune disorders.
- To highlight clinical trial outcomes for adenosine receptor agonists.
Main Methods:
- Literature review of purinergic signaling in immunity.
- Analysis of adenosine's immunomodulatory effects.
- Examination of clinical trial data for adenosine-based therapeutics.
Main Results:
- Adenosine receptors are widely expressed on immune cells.
- Adenosine exhibits both anti-inflammatory and, surprisingly, pro-inflammatory roles.
- Clinical trials show potential for adenosine receptor agonists in treating autoimmune conditions.
Conclusions:
- Adenosine signaling is a critical regulator of immune responses.
- Targeting adenosine receptors represents a promising therapeutic avenue for autoimmune diseases.
- Ongoing clinical trials provide encouraging evidence for adenosine-based therapies.
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
What is the Immune System?
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Endocrine Signaling
Sympathetic Signaling
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
The JAK-STAT Signaling Pathway

